본문 바로가기
KERD
논문KCI 등재

Senotherapeutics: emerging strategy for healthy aging and age-related disease

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류화학

초록

Cellular senescence (CS) is one of hallmarks of aging and accumulation of senescent cells (SCs) with age contributes to tissue or organismal aging, as well as the pathophysiologies of diverse age-related diseases (ARDs). Genetic ablation of SCs in tissues lengthened health span and reduced the risk of age-related pathologies in a mouse model, suggesting a direct link between SCs, longevity, and ARDs. Therefore, senotherapeutics, medicines targeting SCs, might be an emerging strategy for the extension of health span, and prevention or treatment of ARDs. Senotherapeutics are classified as senolytics which kills SCs selectively; senomorphics which modulate functions and morphology of SCs to those of young cells, or delays the progression of young cells to SCs in tissues; and immune-system mediators of the clearance of SCs. Some senolytics and senomorphics have been proven to markedly prevent or treat ARDs in animal models. This review will present the current status of the development of senotherapeutics, in relation to aging itself and ARDs. Finally, future directions and opportunities for senotherapeutics use will discussed. This knowledge will provide information that can be used to develop novel senotherapeutics for health span and ARDs.

Abstract

Cellular senescence (CS) is one of hallmarks of aging and accumulation of senescent cells (SCs) with age contributes to tissue or organismal aging, as well as the pathophysiologies of diverse age-related diseases (ARDs). Genetic ablation of SCs in tissues lengthened health span and reduced the risk of age-related pathologies in a mouse model, suggesting a direct link between SCs, longevity, and ARDs. Therefore, senotherapeutics, medicines targeting SCs, might be an emerging strategy for the extension of health span, and prevention or treatment of ARDs. Senotherapeutics are classified as senolytics which kills SCs selectively; senomorphics which modulate functions and morphology of SCs to those of young cells, or delays the progression of young cells to SCs in tissues; and immune-system mediators of the clearance of SCs. Some senolytics and senomorphics have been proven to markedly prevent or treat ARDs in animal models. This review will present the current status of the development of senotherapeutics, in relation to aging itself and ARDs. Finally, future directions and opportunities for senotherapeutics use will discussed. This knowledge will provide information that can be used to develop novel senotherapeutics for health span and ARDs.

참고문헌 (76)

  1. Hayflick L, "The serial cultivation of human diploid cell strains", Exp Cell Res, 25, pp.585~621 (1961)
  2. Campisi J, "Aging, cellular senescence, and cancer", Annu Rev Physiol, 75, pp.685~705 (2013)
  3. Wang C, "DNA damage response and cellular senescence in tissues of aging mice", Aging Cell, 8, pp.311~323 (2009)
  4. He S, "Senescence in Health and Disease", Cell, 169, pp.1000~1011 (2017)
  5. Leong I, "Sustained caloric restriction in health", Nat Rev Endocrinol, 14, pp.322~ (2018)
  6. Redman LM, "Metabolic Slowing and Reduced Oxidative Damage with Sustained Caloric Restriction Support the Rate of Living and Oxidative Damage Theories of Aging", Cell Metab, 27, pp.805~815 (2018)[DOI]
  7. Roth GS, "Manipulation of health span and function by dietary caloric restriction mimetics", Ann N Y Acad Sci, 1363, pp.5~10 (2016)
  8. Wei M, "Fasting-mimicking diet and markers", risk factors for aging, diabetes, cancer, and cardiovascular disease, 2017, pp.9, 377~
  9. Mitchell SJ, "The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet", Cell Rep, 6, pp.836~843 (2014)
  10. Burkewitz K, "AMPK at the nexus of energetics and aging", Cell Metab, 20, pp.10~25 (2014)
  11. Harrison DE, "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice", Nature, 460, pp.392~395 (2009)
  12. Shuhei Nakamura, "Autophagy and Longevity", Molecules and Cells, 41(1), pp.65~72 (2018), 한국분자세포생물학회
  13. Moskalev A, "Geroprotectors : A Unified Concept and Screening Approaches", Aging Dis, 8, pp.354~363 (2017)
  14. Conese M, "The Fountain of Youth: A Tale of Parabiosis, Stem Cells, and Rejuvenation", Open Med (Wars), 12, pp.376~383 (2017)
  15. Villeda SA, "Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice", Nat Med, 20, pp.659~663 (2014)
  16. Castellano JM, "Human umbilical cord plasma proteins revitalize hippocampal function in aged mice", Nature, 544, pp.488~492 (2017)
  17. Lopez-Otin C, "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
  18. Munoz-Espin D, "Cellular senescence : from physiology to pathology", Nat Rev Mol Cell Biol, 15, pp.482~496 (2014)
  19. Baker DJ, "Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders", Nature, 479, pp.232~236 (2011)
  20. Baker DJ, "Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan", Nature, 530, pp.184~189 (2016)
  21. Xu M, "Targeting senescent cells enhances adipogenesis and metabolic function in old age", Elife, 4, pp.e12997~ (2015)
  22. Ogrodnik M, "Cellular senescence drives age-dependent hepatic steatosis", Nat Commun, 8, pp.15691~ (2017)
  23. Farr JN, "Targeting cellular senescence prevents age-related bone loss in mice", Nat Med, 23, pp.1072~1079 (2017)
  24. Bussian TJ, "Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline", Nature, 562, pp.578~582 (2018)
  25. Childs BG, "Senescent intimal foam cells are deleterious at all stages of atherosclerosis", Science, 354, pp.472~477 (2016)
  26. Jeon OH, "Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment", Nat Med, 23, pp.775~781 (2017)
  27. Xu M, "Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice", J Gerontol A Biol Sci Med Sci, 72, pp.780~785 (2017)
  28. Xu M, "Senolytics improve physical function and increase lifespan in old age", Nat Med, 24, pp.1246~1256 (2018)
  29. Zhu Y, "The Achilles' heel of senescent cells : from transcriptome to senolytic drugs", Aging Cell, 14, pp.644~658 (2015)
  30. Niedernhofer LJ, "Senotherapeutics for healthy ageing", Nat Rev Drug Discov, 17, pp.377~ (2018)
  31. Roos CM, "Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice", Aging Cell, 15, pp.973~977 (2016)
  32. Schafer MJ, "Cellular senescence mediates fibrotic pulmonary disease", Nat Commun, 8, pp.14532~ (2017)
  33. Chang J, "Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice", Nat Med, 22, pp.78~83 (2016)
  34. Zhu Y, "Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors", Aging Cell, 15, pp.428~435 (2016)
  35. Yosef R, "Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL", Nat Commun, 7, pp.11190~ (2016)
  36. Zhu Y, "New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463", Aging (Albany NY), 9, pp.955~963 (2017)
  37. Moncsek A, "Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout(Mdr2(-", -))mice, 2018, pp.67, 247~259
  38. Fuhrmann-Stroissnigg H, "Identification of HSP90 inhibitors as a novel class of senolytics", Nat Commun, 8, pp.422~ (2017)
  39. Wang Y, "Discovery of piperlongumine as a potential novel lead for the development of senolytic agents", Aging(Albany NY), 8, pp.2915~2926 (2016)
  40. Hwang HV, "Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells", PLoS One, 13, pp.e0190374~ (2018)
  41. Samaraweera L, "A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC", Sci Rep, 7, pp.1900~ (2017)
  42. Kim YH, "Senescent tumor cells lead the collective invasion in thyroid cancer", Nat Commun, 8, pp.15208~ (2017)
  43. Milanovic M, "Senescenceassociated reprogramming promotes cancer stemness", Nature, 553, pp.96~100 (2018)
  44. Baar MP, "Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging", Cell, 169, pp.132~147 (2017)[DOI]
  45. Liu P, "Anti-Aging Implications of Astragalus Membranaceus(Huangqi) : A Well-Known Chinese Tonic", Aging Dis, 8, pp.868~886 (2017)
  46. Hubbard BP, "Small molecule SIRT1 activators for the treatment of aging and age-related diseases", Trends Pharmacol Sci, 35, pp.146~154 (2014)
  47. Lamming DW, "Rapalogs and mTOR inhibitors as anti-aging therapeutics", J Clin Invest, 123, pp.980~989 (2013)
  48. Si H, "Dietary antiaging phytochemicals and mechanisms associated with prolonged survival", J Nutr Biochem, 25, pp.581~591 (2014)
  49. Soto-Gamez A, "Therapeutic interventions for aging : the case of cellular senescence", Drug Discov Today, 22, pp.786~795 (2017)
  50. Chondrogianni N, "Proteasome activation : An innovative promising approach for delaying aging and retarding age-related diseases", Ageing Res Rev, 23, pp.37~55 (2015)
  51. Chung HY, "Molecular inflammation as an underlying mechanism of the aging process and age-related diseases", J Dent Res, 90, pp.830~840 (2011)
  52. Franceschi C, "Inflammaging and 'Garb-aging'", Trends Endocrinol Metab, 28, pp.199~212 (2017)
  53. Tilstra JS, "NF-kappaB in Aging and Disease", Aging Dis, 2, pp.449~465 (2011)
  54. Tilstra JS, "NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice", J Clin Invest, 122, pp.2601~2612 (2012)
  55. Xu M, "JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age", Proc Natl Acad Sci U S A, 112, pp.E6301~E6310 (2015)
  56. Kang HT, "Chemical screening identifies ATM as a target for alleviating senescence", Nat Chem Biol, 13, pp.616~623 (2017)
  57. Cao K, "Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts", J Clin Invest, 121, pp.2833~2844 (2011)
  58. Lee SJ, "Interruption of progerin-lamin A", C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype, 2016, pp.126, 3879~3893
  59. Yang HH, "Inhibitory effects of juglanin on cellular senescence in human dermal fibroblasts", J Nat Med, 68, pp.473~480 (2014)
  60. Hyo Hyun Yang, "Quercetin-3-O-b-D-glucuronide isolated from Polygonum aviculare inhibits cellular senescence in human primary cells", Archives of Pharmacal Research, 37(9), pp.1219~1233 (2014), 대한약학회
  61. 양효현, "Inhibitory effects of (2)-loliolide on cellular senescence in human dermal fibroblasts", Archives of Pharmacal Research, 38(5), pp.876~884 (2015), 대한약학회
  62. 양효현, "Inhibitory effects of quercetagetin 3,40-dimethyl ether purified from Inula japonica on cellular senescence in human umbilical vein endothelial cells", Archives of Pharmacal Research, 38(10), pp.1857~1864 (2015), 대한약학회
  63. Bae YU, "Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF", FGF pathway, 2016, pp.30, 1276~1286
  64. Bae YU, "Embryonic stem cell-derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF--receptor 2pathway", J Gerontol A Biol Sci Med Sci (2018)
  65. Burton DGA, "Cellular senescence : Immunosurveillance and future immunotherapy", Ageing Res Rev, 43, pp.17~25 (2018)
  66. Demaria M, "An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA", Dev Cell, 31, pp.722~733 (2014)
  67. Krizhanovsky V, "Senescence of activated stellate cells limits liver fibrosis", Cell, 134, pp.657~667 (2008)
  68. Munoz-Espin D, "Programmed cell senescence during mammalian embryonic development", Cell, 155, pp.1104~1118 (2013)
  69. Sagiv A, "NKG2D ligands mediate immunosurveillance of senescent cells", Aging (Albany NY), 8, pp.328~344 (2016)
  70. Kim KM, "Identification of senescent cell surface targetable protein DPP4", Genes Dev, 31, pp.1529~1534 (2017)
  71. Kang TW, "Senescence surveillance of pre-malignant hepatocytes limits liver cancer development", Nature, 479, pp.547~551 (2011)
  72. van Deursen JM, "The role of senescent cells in ageing", Nature, 509, pp.439~446 (2014)
  73. Childs BG, "Cellular senescence in aging and age-related disease : from mechanisms to therapy", Nat Med, 21, pp.1424~1435 (2015)
  74. Kim TW, "Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system", Exp Gerontol, 43, pp.286~295 (2008)
  75. Thapa RK, "Progressive slowdown", prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles, 2017, pp.7, 43299~
  76. Nguyen HT, "CD9monoclonal antibody-conjugated PEGylated liposomes for targeted delivery of rapamycin in the treatment of cellular senescence", Nanotechnology, 28, pp.095101~ (2017)

관련 논문AI추천

이 간행물의 다른 논문 (11건)